Medical News

Effect of intensive lifestyle intervention on bodyweight and...

Our findings show that the intensive lifestyle intervention led to significant weight loss at 12 months, and was...

22 May 2020

The association between maternal renal function and pregnanc...

Despite its recognized limitations in pregnancy, lower eGFR values were associated with increased risk of adverse...

21 May 2020

What Next After Metformin in Type 2 Diabetes? Selecting the...

This study identified patients’ phenotypic characteristics that may have the potential to influence individual...

20 May 2020

Whole-Grain Processing and Glycemic Control in Type 2 Diabet...

Consuming less-processed whole-grain foods over 2 weeks improved measures of glycemia in free-living adults with...

19 May 2020

Key Trials

VERIFY: Early Vildagliptin and Metformin Combination Therapy Associated with Greater and Long-term Glycemic Durability vs. Metformin Monotherapy

Newly diagnosed type 2 diabetes mellitus patients treated with an early combination therapy of vildagliptin plus metformin experience greater...

Moderate Weight Loss following Diabetes Diagnosis May Reduce Long-term CVD Risk

The study demonstrates that a moderate weight loss (≥5%) in type-2 diabetes patients within a year of the disease diagnosis cuts down the risk of...

CREDENCE: Impact of Canagliflozin on Cardio-Renal Outcomes in T2DM Patients with CKD

According to the findings of the CREDENCE trial, canagliflozin rendered protection against renal and cardiovascular outcomes in type-2 diabetes...

SGLT2 Inhibitors for Prevention of CV and Renal Outcomes in T2DM Patients: Does the ASCVD Status Matter?

Findings of the study showed that SGLT2 inhibitors effectively reduce the risk of MACE, renal outcomes, and hospitalizations for HF in T2DM patients...

Patient Education

Diabetic Retinopathy

Diabetic retinopathy (DR) is the most common and most serious of the ocular complications of diabetes mellitus. This patient education leaflet on DR...

Diabetes Management During Ramadan

Fasting & feasting during Ramadan in diabetes patients is associated with altered glucose level which may lead to low or high blood sugar level....

Know More about Diabetes

Diabetes implies high blood sugar levels in blood. Find out more about the cause, risk factors and complications associated with this disease.

Yoga

The ancient science of yoga provides various health benefits to an individual. Know more about the ‘asanas’ that are beneficial for diabetes patients...

Our Publications

Mind Matters (Issue 3) - Role of Escitalopram in the Treatment of Comorbid Depression and Diabetes

The presence of depression in patients with diabetes mellitus is of vast importance, as it is usually associated with poor disease control, adverse...

Diabetes Management Series: Cholesterol

Most relevant information on management of dyslipidemia, a common comorbidity observed in diabetes patients, has been summarised in this document.

Drug Therapy for Management of Hyperglycaemia

Brief information on the treatment strategy and selection of oral antihyperglycemic agents in type 2 diabetes is summarised in this document.

Diabetes Management Series: Hypertension

Hypertension elevates the risk of micro-and macro-vascular complications in diabetes. Here is a summary on the BP treatment goals in diabetes...

Slide Library

Interface of Diabetes Mellitus with Urology

Know about the urological and andrological complications of diabetes mellitus and their underlying pathophysiological mechanisms.  

 
Email this page
Urologic Complications of Diabetes

Know how diabetes mellitus causes urological diseases and the underlying pathophysiological mechanisms responsible for it.  

 
Email this page
Management of Diabetes during Ramadan

Fasting & feasting during Ramadan in diabetes patients is associated with increased risk of complications such as hypoglycemia, hyperglycemia,...

 
Email this page
Clinical Practice Recommendations: ADA 2014

This slide set summarizes the key 2014 clinical practice recommendations of the American Diabetes Association (ADA) on the screening, diagnosis and...

 
Email this page

Poll

Which is your preferred DPP4 inhibitor for your type 2 diabetes patients with ESRD?
Sitagliptin
24% (5 votes)
Vildagliptin
24% (5 votes)
Linagliptin
48% (10 votes)
No specific choice
5% (1 vote)
Don’t prefer a DPP4 inhibitor
0% (0 votes)
Total votes: 21